Hornfeldt C S, Kitto K F, Larson A A
Department of Veterinary PathoBiology, University of Minnesota, St. Paul 55108, USA.
Eur J Pharmacol. 1996 Jun 13;306(1-3):15-22. doi: 10.1016/0014-2999(96)00199-9.
Behaviors induced in mice by intrathecal injections of either N-methyl-D-aspartate (NMDA) or kainic acid are modulated by NH2-terminal fragments of substance P, such as substance P-(1-7). The action of substance P-(1-7) on kainic acid depends on sigma receptor activity. The present study was designed to test the hypothesis that sigma receptor activity is also necessary for modulation of NMDA by substance P-(1-7). Intrathecal injection of mice with NMDA results in a brief burst of biting and scratching behaviors which decrease in intensity when NMDA is injected repeatedly at 2 min intervals. Pretreatment with 1,3-di-O-tolylguanidine (DTG), a ligand at both sigma 1 and sigma 2 sites, converted NMDA-induced desensitization to sensitization, thereby enhancing tonic NMDA receptor activity. Although haloperidol (30 min) alone was without effect, the potentiation of NMDA-induced activity by DTG was abolished by haloperidol but unaffected by an equimolar dose of either spiperone or thiothixine, two dopamine receptor antagonists. When mice received substance P-(1-7), NMDA-induced behaviors were initially inhibited but then potentiated. Pretreatment with haloperidol prevented both inhibitory and potentiative effects of substance P-(1-7) whereas thiothixine did not, suggesting inhibitory as well as potentiative modulation of NMDA by sigma receptor activity. Endogenous sigma 1 receptor activity may enhance NMDA receptor activity as a treatment regimen that down-regulates sigma 1 binding also inhibited responses to NMDA. In contrast, pretreatment with haloperidol just 5 min prior to challenge, which blocks both sigma 1 and sigma 2 receptor activity, increased responses to NMDA suggesting an inhibitory effect of sigma 2 receptor activity. In summary, modulation of NMDA by substance P-(1-7) appears to depend on activity at sigma sites as substance P-(1-7) mimicked the potentiative effects of DTG, while haloperidol inhibited the effects of both DTG and substance P-(1-7).
鞘内注射N-甲基-D-天冬氨酸(NMDA)或海藻酸诱导的小鼠行为可被P物质的NH2末端片段(如P物质-(1-7))调节。P物质-(1-7)对海藻酸的作用取决于σ受体活性。本研究旨在检验σ受体活性对于P物质-(1-7)调节NMDA是否也是必需的这一假设。给小鼠鞘内注射NMDA会导致短暂的咬和抓挠行为爆发,当以2分钟的间隔重复注射NMDA时,这些行为的强度会降低。1,3-二-O-甲苯基胍(DTG)是σ1和σ2位点的配体,用其预处理可将NMDA诱导的脱敏转变为敏感化,从而增强持续性NMDA受体活性。虽然单独使用氟哌啶醇(30分钟)没有效果,但氟哌啶醇可消除DTG对NMDA诱导活性的增强作用,而等摩尔剂量的螺哌隆或硫利达嗪(两种多巴胺受体拮抗剂)对其没有影响。当小鼠接受P物质-(1-7)时,NMDA诱导的行为最初受到抑制,但随后增强。氟哌啶醇预处理可阻止P物质-(1-7)的抑制和增强作用,而硫利达嗪则不能,这表明σ受体活性对NMDA具有抑制和增强调节作用。内源性σ1受体活性可能会增强NMDA受体活性,因为下调σ1结合的治疗方案也会抑制对NMDA的反应。相反,在激发前仅5分钟用氟哌啶醇预处理,可阻断σ1和σ2受体活性,增加对NMDA的反应,这表明σ2受体活性具有抑制作用。总之,P物质-(1-7)对NMDA的调节似乎取决于σ位点的活性,因为P物质-(1-7)模拟了DTG的增强作用,而氟哌啶醇则抑制了DTG和P物质-(1-7)的作用。